FDA Brief

Warning letters Drugs

FDA warning letter to

Hikal Limited

Issued Aug 20, 2025Posted Sep 9, 2025Center for Drug Evaluation and Research (CDER)

CGMP/Active Pharmaceutical Ingredient (API)/Adulterated. We haven't summarized this letter yet. Read it on fda.gov.